Literature DB >> 31061705

Con: Liver Biopsy Remains the Gold Standard to Evaluate Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.

Daniel Berger1, Vishal Desai1, Sujit Janardhan1.   

Abstract

Entities:  

Year:  2019        PMID： 31061705      PMCID： PMC6491029          DOI： 10.1002/cld.740

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  7 in total

1.  Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Paul Angulo; David E Kleiner; Sanne Dam-Larsen; Leon A Adams; Einar S Bjornsson; Phunchai Charatcharoenwitthaya; Peter R Mills; Jill C Keach; Heather D Lafferty; Alisha Stahler; Svanhildur Haflidadottir; Flemming Bendtsen
Journal:  Gastroenterology       Date:  2015-04-29       Impact factor: 22.682

2.  Complications of cardiac catheterization in the current era: a single-center experience.

Authors:  B Chandrasekar; S Doucet; L Bilodeau; J Crepeau; P deGuise; J Gregoire; R Gallo; G Cote; R Bonan; M Joyal; G Gosselin; J F Tanguay; I Dyrda; M Bois; A Pasternac
Journal:  Catheter Cardiovasc Interv       Date:  2001-03       Impact factor: 2.692

3.  Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial.

Authors:  Leonard B Seeff; Gregory T Everson; Timothy R Morgan; Teresa M Curto; William M Lee; Marc G Ghany; Mitchell L Shiffman; Robert J Fontana; Adrian M Di Bisceglie; Herbert L Bonkovsky; Jules L Dienstag
Journal:  Clin Gastroenterol Hepatol       Date:  2010-04-01       Impact factor: 11.382

4.  Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations.

Authors:  Laurent Castéra; Juliette Foucher; Pierre-Henri Bernard; Françoise Carvalho; Daniele Allaix; Wassil Merrouche; Patrice Couzigou; Victor de Lédinghen
Journal:  Hepatology       Date:  2010-03       Impact factor: 17.425

Review 5.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

6.  Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.

Authors:  Kento Imajo; Takaomi Kessoku; Yasushi Honda; Wataru Tomeno; Yuji Ogawa; Hironori Mawatari; Koji Fujita; Masato Yoneda; Masataka Taguri; Hideyuki Hyogo; Yoshio Sumida; Masafumi Ono; Yuichiro Eguchi; Tomio Inoue; Takeharu Yamanaka; Koichiro Wada; Satoru Saito; Atsushi Nakajima
Journal:  Gastroenterology       Date:  2015-12-08       Impact factor: 22.682

7.  Assessment of risk factors for delayed colonic post-polypectomy hemorrhage: a study of 15553 polypectomies from 2005 to 2013.

Authors:  Qiang Zhang; Sheng li An; Zhen yu Chen; Feng-Hua Fu; Bo Jiang; Fa chao Zhi; Yang Bai; Wei Gong
Journal:  PLoS One       Date:  2014-10-01       Impact factor: 3.240
  7 in total
  15 in total

Review 1.  Magnetic Resonance Imaging of Liver Fibrosis, Fat, and Iron.

Authors:  Christopher L Welle; Michael C Olson; Scott B Reeder; Sudhakar K Venkatesh
Journal:  Radiol Clin North Am       Date:  2022-07-15       Impact factor: 1.947

2.  Relationship between liver fat content and lifestyle factors in adults with metabolic syndrome.

Authors:  Saara Laine; Tanja Sjöros; Taru Garthwaite; Maria Saarenhovi; Petri Kallio; Eliisa Löyttyniemi; Henri Vähä-Ypyä; Harri Sievänen; Tommi Vasankari; Kirsi Laitinen; Noora Houttu; Ekaterina Saukko; Juhani Knuuti; Virva Saunavaara; Ilkka H A Heinonen
Journal:  Sci Rep       Date:  2022-10-19       Impact factor: 4.996

3.  Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors.

Authors:  Dieter Broering; Mohamed Shawkat; Ali Albenmousa; Faisal Abaalkhail; Saleh Alabbad; Waleed Al-Hamoudi; Saad Alghamdi; Saleh Alqahthani; Ahmad Jaafari; Roberto Troisi; Khalid Bzeizi
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

Review 4.  Magnetic resonance elastography of the liver: everything you need to know to get started.

Authors:  Kay M Pepin; Christopher L Welle; Flavius F Guglielmo; Jonathan R Dillman; Sudhakar K Venkatesh
Journal:  Abdom Radiol (NY)       Date:  2021-11-01

5.  Preliminary experience with 3T magnetic resonance elastography imaging of the liver.

Authors:  Anagha Joshi; Mridula M Muthe; Vikrant Firke; Harshal Badgujar
Journal:  SA J Radiol       Date:  2021-05-12

Review 6.  Hepatobiliary complications from ruptured silicone breast implants - a comprehensive literature review.

Authors:  Joshua Agilinko; Dharshanan Raj; Ken Vin Wong; Daniele Fanelli; Nicklaus Ng; Bertrand Agilinko; Mohammad Hasan
Journal:  Ger Med Sci       Date:  2021-05-25

Review 7.  MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis.

Authors:  Nancy de Los Ángeles Segura-Azuara; Carlos Daniel Varela-Chinchilla; Plinio A Trinidad-Calderón
Journal:  Front Med (Lausanne)       Date:  2022-01-13

Review 8.  Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches.

Authors:  Eirini Martinou; Marinos Pericleous; Irena Stefanova; Vasha Kaur; Angeliki M Angelidi
Journal:  Diagnostics (Basel)       Date:  2022-02-04

9.  Electrical Impedance-Based Characterization of Hepatic Tissue with Early-Stage Fibrosis.

Authors:  Susana Fuentes-Vélez; Sharmila Fagoonee; Alessandro Sanginario; Marco Pizzi; Fiorella Altruda; Danilo Demarchi
Journal:  Biosensors (Basel)       Date:  2022-02-13

Review 10.  Nonalcoholic Fatty Liver Disease: Could It Be the Next Medical Tsunami?

Authors:  Priyanka Bhandari; Amit Sapra; Mohitkumar S Ajmeri; Christine E Albers; Devanshika Sapra
Journal:  Cureus       Date:  2022-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.